uniQure to Participate in Multiple Upcoming Industry Conferences in September

Rhea-AI Summary

uniQure N.V. (NASDAQ: QURE) announced its participation in several investor and scientific conferences from September 8 to September 30, 2021. Key events include Citi’s 16th Annual BioPharma Virtual Conference, the Wells Fargo 2021 Virtual Healthcare Conference with a fireside chat featuring CEO Matt Kapusta, and the H.C. Wainwright 23rd Annual Global Investment Conference. Additionally, Ricardo Dolmetsch will participate in discussions at the SVB Leerink CybeRx Series and the 2021 Cantor Virtual Global Healthcare Conference. uniQure aims to advance gene therapies for severe genetic diseases.

LEXINGTON, Mass. and AMSTERDAM, Sept. 07, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences:

• Citi’s 16^th Annual BioPharma Virtual Conference, September 8 - 10, 2021
  
  
  • Members of uniQure’s management team, including Matt Kapusta, chief executive officer, will participate in virtual one-on-one investor meetings throughout the day on Thursday, September 9.
    
    
• Wells Fargo 2021 Virtual Healthcare Conference, September 9 - 10, 2021
  
  
  • Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Friday, September 10.
    
    
  • A fireside chat with Matt Kapusta will take place the same day from 12:00 to 12:30 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website.
    
    
• H.C. Wainwright 23^rd Annual Global Investment Conference, September 13 - 15, 2021
  
  
  • Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, September 15.
    
    
  • A pre-recorded fireside chat with Matt Kapusta will be available on September 13^th through H.C. Wainwright or can accessed through the link displayed in the Investors & Newsroom section of the uniQure website.
    
    
• SVB Leerink CybeRx Series: Neuromuscular, Rare Disease & Genetic Medicines Summit, September 22 - 23, 2021
  
  
  • Members of uniQure’s management team including Ricardo Dolmetsch, Ph.D., president of Research & Development will participate in virtual one-on-one investor meetings throughout the day on Thursday, September 23.
    
    
• 2021 Cantor Virtual Global Healthcare Conference, September 27 - 30, 2021
  
  
  • Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Monday, September 27.
    
    
  • Ricardo Dolmetsch will participate in a fireside chat the same day at 9:20 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website.
    

About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with severe genetic diseases of the central nervous system (CNS) and liver, including clinical programs in hemophilia B and Huntington's disease and preclinical candidates in Fabry disease, spinocerebellar ataxia Type 3, temporal lobe epilepsy, Alzheimer’s, Parkinson’s, and ALS. www.uniQure.com

uniQure Contacts:

FOR INVESTORS:		FOR MEDIA:
Maria E. Cantor	Chiara Russo	Tom Malone
Direct: 339-970-7536	Direct: 617-306-9137	Direct: 339-970-7558
m.cantor@uniQure.com	c.russo@uniQure.com	t.malone@uniQure.com

FAQ

What conferences will uniQure participate in during September 2021?

uniQure will participate in the Citi’s 16th Annual BioPharma Virtual Conference, Wells Fargo 2021 Virtual Healthcare Conference, H.C. Wainwright 23rd Annual Global Investment Conference, SVB Leerink CybeRx Series, and the 2021 Cantor Virtual Global Healthcare Conference.

Who will represent uniQure at the Wells Fargo 2021 Virtual Healthcare Conference?

CEO Matt Kapusta and other members of uniQure’s management team will participate in the Wells Fargo 2021 Virtual Healthcare Conference.

When is the fireside chat with Matt Kapusta scheduled?

The fireside chat with Matt Kapusta is scheduled for September 10, 2021, from 12:00 to 12:30 p.m. ET.

What is the focus of uniQure's gene therapy pipeline?

uniQure's gene therapy pipeline focuses on severe genetic diseases of the central nervous system and liver, including hemophilia B and Huntington's disease.

Where can I access the webcast of the fireside chat?

The webcast of the fireside chat can be accessed through the Investors & Newsroom section of the uniQure website.